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Combining live imaging with the ability to retrieve individual cells of interest remains a technical challenge.
Combining imaging with precise cell retrieval is of particular interest when studying highly dynamic or
transient, asynchronous, or heterogeneous cell biological and developmental processes. Here, we present
a method to encapsulate live cells in a 3D hydrogel matrix, via hydrogel bead compartmentalisation. Using
a small-scale screen, we optimised matrix conditions for the culture and multilineage differentiation of
mouse embryonic stem cells. Moreover, we designed a custom microfluidic platform that is compatible
with live imaging. With this platform we can long-term culture and subsequently extract individual cells-in-
beads by media flow only, obviating the need for enzymatic cell removal from the platform. Specific beads
may be extracted from the platform in isolation, without disrupting the adjacent beads. We show that we
can differentiate mouse embryonic stem cells, monitor reporter expression by live imaging, and retrieve
individual beads for functional assays, correlating reporter expression with functional response. Overall, we
present a highly flexible 3D cell encapsulation and microfluidic platform that enables both monitoring of
cellular dynamics and retrieval for molecular and functional assays.
Introduction
Asynchrony and heterogeneity are key challenges when studying
dynamic processes in biology. These challenges can be overcome
by following individual cells over time using live imaging
systems. Live imaging has proven successful in studying
dynamic processes across systems, from embryonic stem cells1,2
or hematopoietic stem cell differentiation,3 to large-scale in vivo
morphogenesis across multiple organisms (for example4–6).
However, the number of fluorescent channels available, as well
as the phototoxicity associated with imaging, often limit the
number of parameters (e.g. reporters or dyes) that can be
observed at the same time. We can infer morphological
parameters, but determining cell state often requires reporter
systems. We can more accurately infer cell state, and
significantly increase the number of parameters, by using single
cell RNA sequencing. Yet, in transcriptomic analysis, the history
of a cell is typically lost, and we can only place cells in ‘pseudo-
time’ by making significant and hard-to-test assumptions about
the trajectories cells have followed.7 On the other hand,
microfluidic platforms have emerged which promise to
overcome the limitations mentioned above and integrate live
imaging with mRNA sequencing (for example8,9). These systems,
however, often lack versatility, so that it is not possible to recover
cells for functional assays, such as testing differentiation
potential. Furthermore, given the need for most cells to grow in
adherent conditions, enzymatic methods, which require
inactivation steps, would generally need to be used to extract
cells from the device.
Combining live imaging with cell retrieval for functional
and molecular analysis could greatly help us better
understand dynamic cellular process in controlled
conditions. For this purpose, we have designed a highly
flexible cell encapsulation system and microfluidic platform,
and validated it using embryonic stem (ES) cell
differentiation as a model system. Single ES cells possess the
remarkable ability to divide indefinitely while maintaining
the capacity to give rise to all cell types of the adult
organism.10 Exit from the ES cell state and initiation of
differentiation is a key step. However, the study of this
transition is hindered by a large degree of temporal
Lab ChipThis journal is © The Royal Society of Chemistry 2020
aWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre,
University of Cambridge, Puddicombe Way, Cambridge Biomedical Campus,
Cambridge, CB2 0AW, UK. E-mail: cm623@cam.ac.uk, kc370@cam.ac.uk
bDepartment of Biochemistry, University of Cambridge, 80 Tennis Court Road,
Cambridge, CB2 1GA, UK
c Living Systems Institute, University of Exeter, Exeter, EX4 4QD, UK
dDepartment of Physics, University of Cambridge, 19 J J Thomson Avenue,
Cambridge, CB3 0HE, UK
† Electronic supplementary information (ESI) available. See DOI: 10.1039/
d0lc00165a


























































































Lab Chip This journal is © The Royal Society of Chemistry 2020
heterogeneity.11–13 Indeed, at any given point in time during
exit from the ES cell state, cells can be in different stages of
the differentiation process and respond very differently to
differentiation cues.14 This asynchrony has confounded our
understanding of how ES cells change state and initiate
multilineage differentiation.
With these challenges in mind, we set out to design a
platform that would enable: (i) live imaging a dynamic and
asynchronous process using reporter systems; (ii) isolating
individual events for downstream molecular and functional
characterisation at specific timepoints. The platform had to
fulfil two requirements: cells had to be cultured in contact
with extracellular matrix (ECM), without attaching to the
microfluidic device directly; and channels had to be
controlled individually so that specific cells or cell aggregates
of interest could be extracted independently.
Hydrogel beads provide an ideal system to keep cells in
contact with ECM, without direct attachment to a dish or
surface. Previously, it was shown that ES cells can self-renew
and initiate the process of differentiation in agarose-only
beads.15 Here, we optimise conditions for encapsulating cells
in 3D agarose–fibrin hydrogel beads. We also develop a
microfluidic platform that enabled us to retain individual
beads in culture, or extract them for downstream analysis,
using media flow, without the need to enzymatically
dissociate the matrix. Finally, we show that this platform can
be used to follow the asynchronous exit from the ES cell state
over time, and determine the functional properties of cells at
specific points during that process.
Results and discussion
3D agarose–fibrin matrix mini-screen
The foundation for our encapsulation strategy is agarose
beads. However, agarose is biologically inert and does not
provide specific cell adhesion or ECM retention. Therefore,
we sought to optimise the cell encapsulation platform by
providing a biologically active scaffold component. Thrombin
can polymerise fibrinogen molecules to form fibrin scaffolds
that are highly biocompatible and able to bind various ECM
proteins, including laminin.16,17 Moreover, fibrin can be
remodelled and digested by cells over time providing a
system to potentially escape compression associated with cell
division,17 while its stability can be increased by covalent
modification.18 It should be noted, however, that excess
remodelling can eventually lead to disintegration of the
scaffold. To strike a balance between biocompatibility,
degradability and stability, we made use of agarose–fibrin
composite matrices, where agarose provides the non-
degradable scaffold.
To identify the optimal agarose/fibrin scaffold
composition for ES cell differentiation in hydrogel beads, we
designed a 3D matrix screen (adaptable template provided in
Table S1†). ES cells harbouring a Sox1::GFP (a neural marker)
knock-in reporter were embedded in 96-well plates containing
matrices of varying composition, and differentiated towards the
neural lineage (Fig. 1A). We varied the concentration of agarose,
fibrinogen, thrombin and laminin in combination (Table 1),
and examined the effect on differentiation efficiency. Some of
the combinations led to scaffold disintegration over time so that
cells grew adherent at the bottom of the dish and were,
therefore, poor candidates for stable encapsulation. In other
conditions, however, the scaffold was stable, and cells grew in
3D, embedded in the hydrogels. Using visual inspection, we
assigned each well a matrix-integrity score of 1–4. A matrix
integrity scores of 1 indicated scaffolds that disintegrated and
therefore were unsuitable for our current purposes. Integrity
scores of 2 indicated scaffolds that largely disintegrated but
remained partly intact. Integrity scores of 3 indicated scaffolds
that were mostly intact, but partly disintegrated. Wells with a
matrix integrity score of 4 contained only embedded aggregates,
suggesting the gels were stable and would not disintegrate in
the final platform, making these conditions good candidates for
our purposes. After 5 days, we dissolved scaffolds with agarase
and dissociated aggregates into single cells using trypsin. The
differentiation efficiency was analysed by flow cytometry
(Fig. 1A). All conditions resulted in Sox1 upregulation in >70%
of cells (Fig. 1B). Conditions where cells escaped and grew
adherent to the culture plates (matrix-integrity score of 1–2)
showed higher cell numbers, which is likely due to the slightly
higher proliferation rate of ES cells in 2D versus 3D.15
Nevertheless, harvesting cells that escape from their
microenvironment and attach to the microfluidic chip would
necessitate enzymatic methods; thus, we discarded such
conditions.
As expected, agarose concentration was the biggest
determining factor for matrix integrity (Fig. 1C). Notably,
however, in the gels with the highest matrix integrity,
increased fibrinogen concentration showed a slight negative
correlation with the percentage of Sox1::GFP positive cells
and cell numbers (Fig. 1D). Laminin and thrombin
concentration did not show significant trends on their own
(not shown). Taken together, our results indicate that the
optimal conditions for ES cell differentiation were in
hydrogel beads formed under the higher agarose
concentrations and lower fibrin. However, fibrin was still
necessary, as omitting fibrin altogether resulted in increased
cell death after 3 days in culture (Fig. 1E). We presume this is
because fibrin co-polymerises with agarose and allows gels to
bind and retain laminin, and because, at low density, cells
require matrix attachment to efficiently survive and
differentiate. Thus, we chose to carry forward the condition
which resulted in the highest matrix stability score, cell
proliferation and differentiation efficiency [1% agarose, 0.075
mg ml−1 fibrinogen, 0.5 U ml−1 thrombin and 3 ng ml−1
laminin, Fig. 1B, black arrows].
Functionalised hydrogel beads support multilineage
differentiation of mES cells
Next, we examined whether we could generate usable
hydrogel beads with the optimised matrix conditions. To this
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Fig. 1 3D matrix mini-screen. A. Schematic of 3D matrix screen to determine hydrogel composition for efficient neural differentiation. B.
Percentage Sox1::GFP positive cells and number of cells on day 5 of neural differentiation in beads. Each dot represents a different matrix condition,
coloured according to a matrix integrity score. The matrix integrity score was assigned based on visual inspection of each well under a light
microscope. Scores were assigned as follows: 4 = all cells in aggregates embedded in hydrogel, 3 = most cells in aggregates embedded in hydrogel
but some cells seen growing adherent at the bottom of the dish, 2 = most cells growing adherent to the bottom of the well but a few 3D aggregates
embedded in the matrix visible, 1 = all cells growing adherent to the bottom of the well and no matrix visible. Black arrows indicate the conditions
selected for further characterisation, as they resulted in a large number of Sox1 positive cells, while maintaining maximum matrix integrity (score of
4). C. Effect of agarose concentration on matrix integrity. D. Effect of fibrinogen concentration on percentage of Sox1::GFP cells (linear regression
showing negative correlation, R2 = 0.934, p = 0.022) and number of cells (E) after 5 days of differentiation. E. Cell survival in agarose/fibrinogen/
laminin composite gels vs. agarose/laminin-only matrices on day 3. DAPI is able to enter only dead or dying cells. Scale bar 100 μm.
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end, we used a flow-focusing microfluidic encapsulation
device.15 Low-melt agarose was dissolved and cooled to 37 °C
as previously described,15 before adding fibrinogen and
laminin. This solution was fed through one inlet of the
encapsulation device. Newly formed agarose beads were
collected in tubes on ice. Basal media supplemented with
thrombin was added to the collection tube, and agarose–fibrin
beads were de-emulsified by addition of perfluorooctanol
(PFO) (Fig. 2A). Thrombin addition led to fibrin/fibrinogen
incorporation and retention in the hydrogel beads (Fig. 2B).
The beads remained stable and did not attach to the dish.
Next, we tested if the agarose–fibrin beads could sustain
ES cell self-renewal and differentiation. 2% low-melt agarose
solution was heated and subsequently cooled to 37 °C. ES
cells were resuspended in basal media (N2B27) supplemented
with 2× fibrinogen and laminin solution. The agarose and
cell suspension were mixed, and quickly passed through the
cell encapsulation microfluidic device (Fig. 2C). Encapsulated
cells were de-emulsified as shown previously,15 in a media
containing thrombin.
In ES cell culture conditions (2i/LIF), encapsulated cells
proliferated at a rate similar to what was previously reported
in 3D15 and maintained expression of pluripotency markers
Nanog, Klf4 and Oct4 (Fig. 2D). When placed in mesoderm-
inducing conditions, we could detect expression of the pan-
primitive streak marker T(Bra) (Fig. 2E), while in neural
conditions we could detect Sox1 and Sox2 double positive
neural precursor cells (Fig. 2F). Finally, we tested whether the
hydrogel beads were amenable to live imaging. To follow exit
from the ES cell state, we used the Rex1::GFPd2 reporter,
known to mark undifferentiated ES cells in vitro, and the
naïve epiblast in vivo.11 Rex1::GFPd2 is lost in cells that have
irreversibly exited the ES cell state, thereby providing a high-
fidelity reporter for the ES cell state. ES cells harbouring both
Rex1::GFPd2 and a constitutive membrane marker
(mTomato) were encapsulated and driven to exit the ES cell
state in basal media (N2B27). 3D stacks of individual beads
were acquired every 30 min and automatically segmented
using the mTomato membrane marker in order to measure
the total GFP level. This allowed us to track the
downregulation of Rex1::GFPd2 as ES cells exited the naïve,
undifferentiated, ES cell state (Fig. 2G). In agreement with
previous reports,12,14 the downregulation of Rex1::GFPd2 was
asynchronous, with cells in some gel beads downregulating
the reporter before others.
Overall, the data demonstrate that agarose and fibrin can
be successfully co-polymerised in hydrogel beads, enabling
support for both self-renewal and multi-lineage
differentiation. Moreover, the system is compatible with live
imaging. We noted that in some conditions, especially after
5–6 days of culture, cells towards the outside of the aggregate
showed signs of cell death (e.g. fragmented nuclei), possibly
due to those cells being highly compressed. Since
pluripotency transition experiments take place within 48 h of
encapsulation, we do not anticipate this being a limitation.
Moreover, the matrix conditions could be further optimised
for longer term experiments. Finally, the hydrogel beads can
easily be dissolved following agarase treatment (not shown).
Since agarase is not cytotoxic it can be added to culture
media, without a need to deactivate or remove it for
subsequent culture (we found no excess cell death).
Microfluidics for single hydrogel bead culture and retrieval
Next, we designed a microfluidic platform that would allow
culturing cells in beads under live imaging, and extracting
specific beads one at a time. To achieve single-bead control
we designed a 2-layer microfluidic platform using
photolithography. In this design, a figure-8 channel layer
contains individual bead traps (Fig. 3A, insert [i]), inlets and
outlets, and an auxiliary module contains an array of bead
traps (Fig. 3A, insert [ii] and C) and multiple independent
inlets/outlets for immunofluorescence (to allow for fixing,
washes and staining). A second layer was superimposed onto
the channel layer to control media flow by means of PDMS
pneumatic (or Quake) valves (Fig. 3B).19 To achieve complete
channel closure upon valve actuation, the mould of the
channel layer was constructed using a two-step process. First,
non-compressible features were generated with SU8 2100.
Then, features containing the channels under pneumatic
control were superimposed onto the SU8 features, in AZ 40
XT and re-flown by reheating to generate rounded profiles
(Fig. 3A top insert and S1†20).
In the design, a number of valves control inlet/outlet
access. These are actuated to prevent backflow and direct
the media flow to specific outlets and/or auxiliary modules.
Two valves control the direction of media flow into the trap
module, while eight valves provide single channel control.
Table S2† describes the combination of valves and inlets
used for bead loading and culture. Activating different sets
of valves enables controlling the direction of media flow
during culture (Fig. 3D), and removing individual beads
(Fig. 3E). Valve actuation is achieved through a pressure
increase in the valve layer, which is controlled by a MUX
microfluidic flow switch matrix (Elveflow), which can apply
constant pressure over any combination of valves. For the
bead removal to be effective, the sequence and timing of
valve actuations is controlled by a custom MATLAB
graphical user interface (GUI), for which we provide the
code (see Methods). Within the GUI, each combination of
valve actuations was mapped to a specific button relating
to a corresponding bead trap. The user can dictate the flow
direction, channel of interest and destination (outlet vs.
Table 1 Concentration of components tested in combination on the
matrix screen
Agarose% Fibrinogen mg ml−1 Thrombin U ml−1 Laminin μg ml−1
1 0.5 0.25 0.6
0.85 0.2 0.5 0.3
0.70 0.075 1
0.50 0.025
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auxiliary module) through single mouse clicks on the GUI
window.
We tested whether individual beads could be removed without
displacing the remaining beads (Fig. 3F). When the media flow
was directed towards the trap (Fig. 3F, panel 1) hydrogel beads
are held in position. To extract an individual bead, the media
flow was initially redirected towards the desired channel by
closing off all the alternative channels (Fig. 3F, panel 2). Next, the
direction of media flow was reversed to extract the bead of
interest into a well of a 96-well plate (Fig. 3F, panels 3 and 4).
Fig. 2 ES cell differentiation in functionalised hydrogel beads. A. A flow-focusing device is used to generate agarose/fibrin/laminin hydrogel beads
in oil/carrier solution. After incubating on ice to allow agarose polymerisation, fresh media with thrombin is added, as well as PFO, to demulsify
the beads. The aqueous fraction containing agarose beads is used for further experiments. B. Fluorescently labelled fibrin is successfully retained
in microgel beads. White outlines show beads, identified from the brightfield channel. Insert shows overlay of brightfield and fluorescent channel
for a section of the image. C. Strategy for encapsulating ES cells in hydrogel beads. D. Encapsulated ES cells maintained in ES cell media and fixed
for 2 days for immunostaining show expression of pluripotency-associated transcription factors Nanog, Oct4 and Klf4. Nuclei were counterstained
with DAPI. Scale bar 20 μm. E. Encapsulated ES cells were placed in mesoderm-inducing media and fixed for immunostaining on day 3. Oct4/T
double positive cells are early mesoderm progenitors, while Oct4+/T-cells are as-yet uncommitted cells. Scale bar 20 μm. F. Encapsulated ES cells
were directed towards the neural lineage and analysed on day 4 for the expression of transcription factors Sox1 and Sox2. Punctuated DAPI
staining shows dead or dying cells. Scale bar 20 μm. G. Live imaging of differentiating ES cells encapsulated in 3D hydrogels. Membrane tomato
(mTomato) expression was used to segment aggregates in 3D. The average aggregate level was determined for each bead and plotted against the
time after withdrawal of self-renewal signals (2i). Individual tracks and average are shown.
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Fig. 3 Microfluidic platform for independent capture and release of aggregates. A. Schematic of the channel (bottom) layer of the microfluidic
platform showing individual components and modules. (i) Shows individual bead traps, (ii) shows a magnified view of a secondary culture module.
Insert shows cross-section of different channel regions. Thicker segments can be closed by valves. B. Schematic of the overlay of the valve and
channel layer in the final design. C. Brightfield image of a cell, encapsulated in an agarose/fibrin/laminin bead, on the bead trap. D. Valve actuation
and media flow for culture and live imaging. Media flow keeps all beads in position in the traps. E. By actuating a combination of valves (example
shows extraction of bead in trap 8), the media flow along a single channel can be reversed, those allowing for the extraction of a bead of interest.
Media flow is blocked along all other channels, so that all remaining beads remain in the traps. F. Snapshots of live imaging showing valve
actuation (1), and re-direction of media by valve actuation as shown in (E) to removal of a single bead (false colour in green – steps 2–4). While a
neighbouring bead (false colour blue) remains in position (4).
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Notably, the neighbouring bead (Fig. 3F, false colour blue)
remained in position.
Therefore, our platform allows for cell culturing under live
imaging conditions of individual cells/beads, which can be
independently extracted. The platform, moreover, provides a
very high degree of flexibility and scalability. The number of
channels and beads analysed can be doubled by adding two
extra control valves. Moreover, the independent inlets can be
used to carry out media change or drug administration at
precise intervals of time.
Live imaging of differentiation and single cell retrieval for
functional studies
We then designed an experiment to validate the platform. ES
cells can be maintained in an undifferentiated, relatively
homogenous, state in N2B27 basal medium supplemented
with GSK3 and MEK1/2 inhibitors (collectively termed 2i),
with the optional addition of LIF21 (2i/LIF medium). In
N2B27 alone (no inhibitors of cytokines), cells initiate
differentiation.11,21 As cells exit the ES cell state, they lose the
ability to self-renew/survive in ES cell maintenance media (2i/
Fig. 4 Combined platform for live imaging and retrieval of live cells for functional studies. A. Example tracks of single encapsulated cells, tracked
over 27 h during exit from the ES cell state. Cells were automatically segmented using mTomato and the total GFP level determined. Graphs on
the right show total Rex1::GFP levels, normalised to cell/aggregate volume. ‘×’ denotes point of extraction and insert figure shows colony arising
after 5 days in ES cell culture conditions (2i/LIF). On the bottom panel, two cells are initially encapsulated together (white and yellow arrows), but
one cell (yellow arrow) escapes confinement after 11 h. Graph shows quantification of remaining cell. B. Images show examples of beads on traps;
bright field, Rex1::GFPd2 and mTomato marker expression of start and end point of live imaging. Bottom panels show the result of the self-
renewal assay in 2i/LIF. C. Quantification of the total level of GFP, normalised to peak, expression, and the outcome of the self-renewal assay in 2i/
LIF.
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LIF).11 The ability to self-renew correlates with the expression
of Rex1::GFPd2; cells that have extinguished Rex1::GFPd2
expression can no longer self-renew in selective ES cell
culture conditions.12,14 The phenotype of cells with
intermediate levels of Rex1::GFPd2, in part due to asynchrony
in the differentiating population (Fig. 2G and ref. 12), is as
yet unknown.
Our microfluidic platform allows us to image cells live as
they begin to differentiate, as shown by loss of Rex1::GFPd2
expression. To determine if cells with intermediate levels of
Rex1::GFPd2 could self-renew or had irreversibly lost ES cell
identity, we encapsulated Rex1::GFPd2 cells harbouring the
constitutive mTomato membrane marker into hydrogel beads
functionalised with laminin. Individual cell/beads were
captured using the microfluidic platform and the media was
switched from ES cell-maintenance medium to N2B27
differentiation medium (no supplements). This allowed cells
to initiate differentiation as monitored by Rex1::GFPd2
downregulation. We imaged cells every 30 min for 27 h, at
which point they displayed a wide distribution of Rex1::
GFPd2 expression levels.12 Next, we extracted individual cells/
beads from the platform and placed each cell/bead in a well
of a 96 well plate containing selective ES cell culture
conditions (2i/LIF) (Fig. 4A). The capacity to form self-
renewing colonies was determined after 5 days. We found
that cells that retained detectable expression of Rex1::GFPd2,
even if significantly lower than ES cell-controls, could still
self-renew in 2i/LIF (Fig. 4B and C). This shows that the
ability to self-renew in 2i/LIF conditions is lost only after cells
have fully downregulated Rex1::GFPd2 expression. Therefore,
our platform allows us to directly correlate reporter
expression over time with the functional response to
signalling pathways/culture conditions.
Conclusions
In this study we present a versatile platform for integrating
live imaging with individual cell retrieval. To achieve this, we
combine a hydrogel 3D encapsulation system with a
microfluidic platform that is compatible with live imaging
and single clone retrieval. The platform offers the potential
to link the cell's history with cell state, characterised at the
molecular or functional level.
To generate biocompatible and tuneable hydrogel beads,
we developed an agarose-based encapsulation strategy.
Agarose scaffolds are non-toxic and stable but do not allow
for ECM or cell attachment. Indeed, they have been
extensively used for anchorage-independent growth, for
example to screen for transformed cells.22 Thus, we co-
polymerized agarose with fibrin to obtain a composite matrix
capable of binding any ECM protein, such as laminin.
Agarose–fibrin gels have been previously used in combination
with bioprinting to generate hollow scaffolds for modelling
renal proximal tubules on chip.23 Agarose–fibrinogen–
hydroxyapatite aggregates were also used for co-culture of
HUVEC and fibroblast cells.24 In that report, however,
fibrinogen was used as a cell-adhesive component rather
than as a scaffold.24 Also, the use of hydroxyapatite was
essential for the incorporation of fibrinogen. This is likely
due to the absence of thrombin24 which allows for fibrinogen
polymerisation into fibrin.16 By co-polymerising agarose and
fibrin, we have a versatile system that can bind different
ECM proteins, where we can readily customise the stiffness
and degree of matrix degradation/remodelling by changing
the proportion of agarose and fibrin. Furthermore, the
polymerisation technique that was used in the previous
report resulted in a large degree of size variation in the
aggregates, making them unsuitable for microfluidics.24
Therefore, to our knowledge, this is the first report of
customisable ECM-functionalised hydrogel beads compatible
with single cell culture and microfluidic handling.
Importantly, our protocol allows for hydrogel beads to be
formed in mild gelation/polymerisation conditions, in the
absence of harsh chemicals or UV light. The hydrogel matrix
screen approach, for which we provide a template (Table
S1†), as well as the use of functionalised hydrogel beads,
could both provide useful platforms for culture for different
cell types across a number of different applications.
Many microfluidic devices have now been reported to
overcome technical limitations of large-scale cell culture,
single clone retrieval and live imaging. Droplet phenotyping
devices can screen many droplets and/or retrieving droplets
with a particular phenotype (e.g. positive staining for a dye or
protein expression).25–29 This can allow identifying rare or
transient events if enough droplets are screened. However, all
cells must be screened/retrieved simultaneously, and the
history of the cell is lost. A key requirement for our
experiments is to end the experiment for different cells at
different times in order to analyse intermediate steps within
dynamic processes, while retaining a record of the biological
process of interest (i.e. how the cells got to that particular
stage). Alternative cell culture devices, while allowing for
small-scale culture and live imaging of cells,30,31 require cells
to grow adhering to the microfluidic device. Therefore, cells
must be extracted by coring or detaching the chip, high
pressure media flow,32 or flowing enzymatic solutions.33
These set ups, while retaining the history of cells, also often
require all samples to be extracted at once. Our device, on
the other hand, through combining elements of microfluidic
valve technology,34 multiplexing35 and microfluidic droplet
cell encapsulation,36 allows following dynamic biological
processes in real time and easily retrieving specific, transient,
events. We can capture individual hydrogel beads, culture or
differentiate them while performing imaging, and remove
individual beads at specific times while leaving the rest
undisturbed. Since the cells do not adhere to the microfluidic
chip, individual beads can be extracted by changing the
direction of media flow, without using high pressure, having
to flow through cell dissociation reagents (e.g. trypsin), or
destroying the chip.
We have introduced a number of design elements that
make the microfluidic chip scalable beyond 16-channels. The
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valve multiplexing design allows doubling the number of
captured hydrogel beads for each two control valves that are
added.37 By using a high working-distance objecting and
imaging systems capable of fast z-stack acquisition, we could
obtain 3D images compatible with segmentation pipelines.
Finally, the system can be integrated with previously-
validated reporter systems used to infer parameters such as
differentiation status, signalling pathway activity, cell cycle
phase, or many other cellular features. Coupling dynamic
readouts of reporters with end-point functional or molecular
analysis could provide unparalleled information on cell state.
The ability to isolate individual beads while leaving the
remainder undisturbed could prove a useful system for
isolating specific stages in processes that occur
asynchronously or are of transient duration. Overall, we
expect this platform to be adaptable to a wide range of
applications for assessing dynamics of cellular processes.
Methods
Mouse ES cell culture and differentiation
Mouse ES cell culture and differentiation was performed
following previously described protocols.14,38 Briefly, cells
carrying a constitutive tomato marker and a destabilised
form of GFP under the control of the Rex1 promoter were
routinely grown in 2i or 2iLIF [1 μM PD0325901, 3 μM
CHIR99021 with or without 100 U ml−1 leukaemia inhibitor
factor (LIF)] in N2B27 basal media [1 : 2 DMEM/F12 (Sigma-
Aldrich D6421), 1 : 2 Neurobasal (Thermo Fisher 21103049),
0.5X B27 (Invitrogen 17504044), 1X N2.BV (see below), 50 μM
b-mercaptoethanol (Thermo Fisher 31350), 2 mM L-glutamine
(Thermo Fisher 25030081), 12.5 μg ml−1 insulin human
recombinant zinc solution (Thermo Fisher 1258014)]. 100X
N2.BV was made in house [8.791 mg ml−1 apotransferrin
(Sigma Aldrich T1147), 1X DMEM/F12, 0.66% BSA fraction V,
3 μM sodium selenite (Sigma Aldrich S5261), 1.688 mg ml−1
putrescine (Sigma Aldrich P5780), 2.08 μg ml−1 progesterone
(Sigma Aldrich P8783)]. Cells were split every two days and
plated at a density of 1.5 × 104 cells per cm2. Differentiation
in aggregates was carried out by placing hydrogel beads in
N2B27 (without 2i or LIF).
Matrix screen
Low-melt agarose (Lonza SeaPlaque 50105) was dissolved at
twice the concentration required and kept at 37 °C to prevent
polymerisation. 2× thrombin solution was added to each tube
containing agarose. 50 μl of agarose/thrombin were added to
each well of a 96 well plate kept on a hot plate set to 37 °C to
prevent polymerisation. On a separate 96 well plate, basal
media was supplemented with laminin (final concentration
2×) and mixed with cells (final cell concentration per well
3500). 50 μl of the media/laminin/fibrinogen and cell mixture
was added to each well containing agarose/thrombin and
mixed by pipetting while keeping the plate at 37 °C. Once
sufficiently mixed, the plate was placed at 4 °C for 15 min to
allow agarose to polymerise. 100 μl of N2B27 was added once
the hydrogel was polymerised. Cells were differentiated for 5
days, before assigning each well a matrix integrity score
based on visual inspection: 4 = all cells in aggregates
embedded in hydrogel, 3 = most cells in aggregates
embedded in hydrogel but some cells adhering to the culture
plate, 2 = most cells growing adherent to the bottom of the
well but a few 3D aggregates embedded in the matrix visible,
1 = all cells growing adherent to the bottom of the well and
no matrix visible. Next, media was carefully removed and
replaced with 50 μl of fresh N2B27 supplemented with
agarase (Thermo Fisher Scientific EO0461) and trypsin.
Hydrogels were dissolved after 15 min, and gentle pipetting
resulted in a single cell suspension. Differentiation efficiency
was analysed by flow cytometry. A linear regression model on
the average percentage of Sox1 positive cells at each fibrin
concentration was used to determine the level of negative
correlation. A template for customising the matrix screen,
alongside detailed instructions and calculations, is provided
in Table S1.†
Immunofluorescence
Hydrogel beads were fixed in 4% PFA for 30 min at room
temperature, before washing twice with PBS for 5 min each
time. Aggregates were permeabilised and blocked for 2–4 h
in block solution (PBS, 0.3% Triton 100X (Sigma Aldrich
T8787) and 3% Donkey serum (Sigma Aldrich D9663)).
Primary antibodies were diluted in block solution and
incubated overnight at 4 °C with gentle rocking. Beads were
washed three times for 15 min with PBST (PBS, 0.3% Triton
100X) before incubating with secondary antibodies diluted in
block solution. After 3 washes of PBST for 15 min each, beads
were stored at 4 °C in PBS to reduce background before
mounting in VECTASHIELD antifade mounting media (Vector
Laboratories H-1000). Images were acquired on a confocal
laser scanning microscope (Leica SP5). The following primary
antibodies were used: Nanog (1 : 200, eBioscience 14-5761-80),
Oct4 C-10 (1 : 400, Santa Cruz sc5279), Klf4 (1 : 400, R&D
AF3158), T(Bra) (1 : 300, R&D AF2085), Sox2 (1 : 200,
eBioscience 14-9811-82), Sox1 (1 : 200, Cell Signalling 4194).
Alexa Fluor-conjugated secondary antibodies were used (Life
Technologies). Nuclei were stained with DAPI.
Live imaging and analysis
Live imaging of agarose drops outside and inside the
microfluidic device was done using a Zeiss 710 confocal
microscope using an 20× 0.5 EC Epiplan-Neofluar objective. A
custom made-heated black box was used to surround the
microscope and syringe pumps and avoid large temperature
gradients. Ten z-stacks were acquired every 30 min for GFP,
mTomato and bright field. Image analysis outside the
microfluidic chip (Fig. 2G) was carried out using Imaris. The
membrane fluorescent protein (mTomato) was used to
segment cells using Imaris Surfaces. For each region of
interest, the total GFP level and volume was determined. At
each timepoint, GFP levels were normalised to total aggregate
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volume. To quantify GFP levels in beads in the microfluidic
device, we used a custom Matlab code (https://github.com/
CMulas/Beads_3D_segmentation).
Hydrogel bead generation
Low melt agarose (Lonza SeaPlaque 50105) was dissolved at
twice the required concentration (2%) in PBS by heating at 80
°C, before reducing the temperature to 37 °C. Cells were
dissociated to obtain a single cell suspension at a
concentration of 5–10 × 106 cells per ml in 2i supplemented
with 0.15 mg ml−1 (2×) fibrinogen (Sigma Aldrich F4883) and
6 ng ml−1 (2×) laminin (Mouse purified, Merck Millipore
CC095). The agarose solution was mixed 1 : 1 with the cells/
fibrinogen/laminin in 2i media and kept at 37 °C briefly to
avoid polymerisation. The encapsulation was carried out as
previously described (with a few modifications) using tested
parameters to generate 80 μm diameter beads.15 Briefly,
chips were plasma-bonded to glass coverslips and the inlets
were immediately flushed with a solution of 1% PFOTS
(trichloroĲ1H,1H,2H,2H-perfluorooctyl)silane, Sigma Aldrich
448931) in HFE-7500 (3M Novec Engineered Fluid,
Fluorochem 051243). For hydrogel bead generation, one inlet
was used for the agarose/cell suspension and one for the oil/
carrier solution [HFE-7500 supplemented with 0.3% Pico-Surf
1 (Sphere Fluidics)] which were flown through at 6 μl min−1
and 30 μl min−1 respectively. Beads were collected for ∼15
min. Newly formed hydrogel beads were collected on ice and
polymerised for 15 min. Cell culture media (either 2i or
N2B27 alone) was supplemented with 0.5 U ml−1 thrombin
(Sigma Aldrich T4393) and added to the bead/oil emulsion.
Deemulsification was carried out by adding 1H,1H,2H,2H-
perfluorooctanol (PFO) (Alfa Aesar, B20156) directly to the oil
layer, quickly vortexing and extracting the top aqueous layer
containing the hydrogel beads (∼100 beads per μl). These
were temporarily stored in an Eppendorf tube inside a tissue
culture incubator until loading the platform.
Microfluidic platform generation
Mould fabrication. Devices are fabricated from two layers
of PDMS, one for the channels and one for the valves, using
moulds of patterned photoresist on silicon wafers.
Schematics with key features are provided in Fig. 3 and S1;†
CAD files are provided in Fig. S2.†
For the channel layer mould, a silicon wafer was spin-
coated with SU8 2100 (MicroChem, UK) at 3100 RPM to
achieve a 90 μm layer across the wafer surface before baking
for 5 min at 65 °C and 30 minutes at 95 °C. To create the
SU8 features within the 90 μm layer, shown in Fig. S1,† a
photomask (printed by JD Photo Data, Hitchin, UK) was used
with a MJB-4 contact mask aligner (Karl Suss, Munich,
Germany) to selectively expose the SU8 coated wafer for 18 s
(365–405 nm, 20 mW cm−2). Exposed regions in the 90 μm
layer of SU8 crosslink, becoming insoluble. Following a
subsequent post-expose bake of 15 minutes at 95 °C, the
wafer is developed in propylene-glycol-mono-methyl-ether-
acetate (PGMEA) (Merk Millipore) for 7 minutes. This
removes all non-crosslinked areas of SU8, leaving 90 μm high
channels on the wafers surface. Any residue is removed with
isopropanol and the wafer is baked at 200 °C to complete the
SU8-layer fabrication.
The same wafer was then spin coated with AZ 40 XT
(MicroChem, UK) at 900 RPM. A slow-ramped bake from 65–
126 °C was performed over 20 minutes before the spin-and-
bake process was repeated to achieve a double thickness
layer. A photomask with the features marked ‘AZ’ on Fig. S1†
was used to generate the channel segments that can be
closed by valves. The wafer is carefully aligned using the
MJB-4 so the channels of the mask fit between the SU8
channels which are visible though the AZ layer. Exposure
consists of two 90 second rounds using 365–405 nm light at
20 mW cm−2. The wafer is post-exposure baked at 105 °C,
and then immersed in AZ 726 developer (MicroChemicals
GmbH, Ulm, Germany) with occasional water rinses until the
features are revealed. To achieve the rounding of the valve
sections, the wafer is then finally baked for 5 minutes at 110
°C to reflow to a maximum height of 115–120 μm (measured
with stylus profilometer, Dektak, Bruker, MA, USA). To
produce a mould for the valve layer, SU8 2025 was spun
across a silicon wafer at 1700 rpm to produce a feature height
of 35 μm. Bake and exposure protocols followed the
manufacturer's guidelines.
PDMS device fabrication. The channel layer was formed by
spin coating 20 : 1 (base : curing agent) PDMS (Sylgard 184,
Dow Corning) over the channel layer mould described above.
This is sufficient to cover the SU8 and features to create a
thin PDMS membrane. We found that 450 RPM is sufficient
to produce a robust membrane while being thin enough to
deform as a valve. This layer is cured at 60 °C for 6 hours.
The valve layer was formed using 5 : 1 (base : curing agent)
PDMS poured over the valve layer mould to a thickness of 1–
1.5 cm and cured for 1 hour at 60 °C. A scalpel is used to cut
the PDMS chip around the outside of the features to free
from the mould. A 1.5 mm biopsy punch is then used to
create holes (indicated by the circular sections of Fig. 3B and
S1†) for fluidic access to the valve channels. The valve and
channel layers are then exposed, feature side up, to oxygen
plasma for 20 s at 100 W (Diener Electronic GmbH and Co.
KG, Germany). Using a stereo microscope, the two layers are
aligned as in Fig. 3B and brought into contact to bond
together. Following a further 1 hour bake at 60 °C, a scalpel
is used to extract the PDMS chip from the silicon wafer.
Fluidic access is enabled through a 1.5 mm biopsy punch at
the circular sites of Fig. 3B and S1.† To complete the
fabrication process, the PDMS device is bonded to a glass
slide (76 × 52 × 1.2 mm, Fisher Scientific) using the oxygen
plasma protocol described above before baking at 60 °C for
one hour.
Microfluidic platform set up and operation. To prepare
microfluidic chips for use, the bonded PDMS and glass
devices are submerged in sterile PBS and placed into a
vacuum desiccator overnight to fill the channels with PBS.
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Once filled, the chips are placed on the microscope stage.
Environmental controls to replicate the conditions of a cell
culture incubator are provided by a heating plate set to 37 °C
and a CO2 chamber set to supply 7% CO2 in air over the
chip.
For fluidic control, each of the valve inlets are connected
via FEP tubing to the MUX multiplexing unit (Elveflow,
France). The MUX unit can distribute pressure to any
combination of the on-chip microfluidic valves with tuneable
pressure. For fluidic delivery, the channel inlets are
connected via FEP tubing to a syringe pump (Nemesys,
Cetoni). All equipment to control valves, flow and pressure
are housed within a purpose-built cabinet containing a
heater set to 37 °C. The operating conditions and valve set-up
for equilibration, loading, culture and extraction are provided
in Table S2.† Several steps, outlined in Table S3,† were taken
to reduce experimental failures.
The microfluidic device uses 14 of the available MUX
channels (excluding the valves for the auxiliary module). A
pressure source, in this case a Fluigent MFCS-EZ microfluidic
flow control system, with a maximum pressure of 1.3 bar,
connects to the MUX. As the valves within the microfluidic
device are a closed system with the MUX, any combination of
‘open’ or ‘closed’ results in the same pressure in any
actuated valve. The pressure is calibrated at the start of each
experiment to effectively close the on-chip valve when the
corresponding MUX outlet is opened.
Each valve on the microfluidic device is connected to the
MUX channels as shown in Fig. S1.† To deliver beads to the
on-chip traps, a step-by-step protocol is described in Table
S2.† At step 12, the combination of valves directs the bead in
position 16 to either be extracted or delivered to the
secondary culture array by actuating valve C4 or D1
respectively. To specify an individual bead for removal or
relocation, a combination of valves A1–4 and B1–4 are
actuated to deliver fluid flow only to the specified channel.
The various combinations required to remove each bead are
programmed into a MATLAB graphical user interface (https://
github.com/achodgson/mulashodgson2020/blob/master/
Bead_Control_GUI.txt), enabling the user to direct the bead
with a single click.
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